Viewing Study NCT05623267


Ignite Creation Date: 2025-12-25 @ 12:43 AM
Ignite Modification Date: 2026-01-03 @ 11:44 PM
Study NCT ID: NCT05623267
Status: RECRUITING
Last Update Posted: 2023-08-07
First Post: 2022-11-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Sugemalimab as Consolidation Therapy in Patients With LS-SCLC Following cCRT or sCRT
Sponsor: Sun Yat-sen University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module